Skip to main content
Erschienen in: Current Treatment Options in Gastroenterology 4/2017

03.10.2017 | Stomach (DA Johnson, Section Editor)

Current Management of Benign Epithelial Gastric Polyps

verfasst von: Antonio R. Cheesman, MD, David A. Greenwald, MD, Shailja C. Shah, MD

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Opinion statement

Purpose of review Benign epithelial gastric polyps, although typically asymptomatic, are identified incidentally on upper endoscopy in up to 23% of patients. These include fundic gland, hyperplastic, and adenomatous polyps. Their appropriate characterization is critical as some have malignant potential, may be indicative of a gastric mucosal field defect, or may be related to an underlying polyposis syndrome. This review will discuss the current management of benign epithelial gastric polyps.
Recent findings Association of gastric polyps with proton pump inhibitor use, Helicobacter pylori infection, risk of malignant transformation, and association with polyposis syndromes have been the focus of recent literature.
Summary All symptomatic polyps, polyps larger than 1 cm in size, and polyps later found to contain dysplasia or cancer should be completely removed. Additionally, random biopsies from the intervening non-polypoid mucosa should be obtained. Finally, identification of multiple polyps of fundic gland type and/or concomitant dysplasia should raise suspicion for an underlying polyposis syndrome and prompt appropriate workup. Surveillance is generally only indicated if there is confirmed dysplasia and/or carcinoma within the polyp itself or if preneoplastic changes are identified in the non-polypoid gastric mucosa.
Literatur
1.
Zurück zum Zitat Marcial MA, Villafana M, Hernandez-Denton J, Colon-Pagan JR. Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol. 1993;88(10):1711–3.PubMed Marcial MA, Villafana M, Hernandez-Denton J, Colon-Pagan JR. Fundic gland polyps: prevalence and clinicopathologic features. Am J Gastroenterol. 1993;88(10):1711–3.PubMed
2.
Zurück zum Zitat Archimandritis A, Spiliadis C, Tzivras M, Vamvakousis B, Davaris P, Manika Z, et al. Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. Ital J Gastroenterol. 1996;28(7):387–90.PubMed Archimandritis A, Spiliadis C, Tzivras M, Vamvakousis B, Davaris P, Manika Z, et al. Gastric epithelial polyps: a retrospective endoscopic study of 12974 symptomatic patients. Ital J Gastroenterol. 1996;28(7):387–90.PubMed
3.
Zurück zum Zitat Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol. 2000;157(3):747–54.PubMedPubMedCentralCrossRef Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol. 2000;157(3):747–54.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol. 2003;36(5):399–402.PubMedCrossRef Weston BR, Helper DJ, Rex DK. Positive predictive value of endoscopic features deemed typical of gastric fundic gland polyps. J Clin Gastroenterol. 2003;36(5):399–402.PubMedCrossRef
5.
Zurück zum Zitat Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24(9):1341–8.PubMedCrossRef Jalving M, Koornstra JJ, Wesseling J, Boezen HM, DE Jong S, Kleibeuker JH. Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther. 2006;24(9):1341–8.PubMedCrossRef
6.
Zurück zum Zitat Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104(6):1524–32.PubMedCrossRef Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104(6):1524–32.PubMedCrossRef
8.
Zurück zum Zitat Voutilainen M, Mantynen T, Kunnamo I, Juhola M, Mecklin JP, Farkkila M. Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol. 2003;38(1):109–13.PubMedCrossRef Voutilainen M, Mantynen T, Kunnamo I, Juhola M, Mecklin JP, Farkkila M. Impact of clinical symptoms and referral volume on endoscopy for detecting peptic ulcer and gastric neoplasms. Scand J Gastroenterol. 2003;38(1):109–13.PubMedCrossRef
9.
Zurück zum Zitat Papa A, Cammarota G, Tursi A, Montalto M, Cuoco L, Certo M, et al. Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study. Hepato-Gastroenterology. 1998;45(20):579–82.PubMed Papa A, Cammarota G, Tursi A, Montalto M, Cuoco L, Certo M, et al. Histologic types and surveillance of gastric polyps: a seven year clinico-pathological study. Hepato-Gastroenterology. 1998;45(20):579–82.PubMed
10.
Zurück zum Zitat Borch K, Skarsgard J, Franzen L, Mardh S, Rehfeld JF. Benign gastric polyps: morphological and functional origin. Dig Dis Sci. 2003;48(7):1292–7.PubMedCrossRef Borch K, Skarsgard J, Franzen L, Mardh S, Rehfeld JF. Benign gastric polyps: morphological and functional origin. Dig Dis Sci. 2003;48(7):1292–7.PubMedCrossRef
11.
Zurück zum Zitat Ally MR, Veerappan GR, Maydonovitch CL, Duncan TJ, Perry JL, Osgard EM, et al. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci. 2009;54(12):2617–22.PubMedCrossRef Ally MR, Veerappan GR, Maydonovitch CL, Duncan TJ, Perry JL, Osgard EM, et al. Chronic proton pump inhibitor therapy associated with increased development of fundic gland polyps. Dig Dis Sci. 2009;54(12):2617–22.PubMedCrossRef
12.
Zurück zum Zitat Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Avsar E, Sav A, Tozun N. Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients. World J Gastroenterol. 2003;9(10):2236–9.PubMedPubMedCentralCrossRef Gencosmanoglu R, Sen-Oran E, Kurtkaya-Yapicier O, Avsar E, Sav A, Tozun N. Gastric polypoid lesions: analysis of 150 endoscopic polypectomy specimens from 91 patients. World J Gastroenterol. 2003;9(10):2236–9.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B, British Society of G. The management of gastric polyps. Gut. 2010;59(9):1270–6.PubMedCrossRef Goddard AF, Badreldin R, Pritchard DM, Walker MM, Warren B, British Society of G. The management of gastric polyps. Gut. 2010;59(9):1270–6.PubMedCrossRef
14.
Zurück zum Zitat Ginsberg GG, Al-Kawas FH, Fleischer DE, Reilly HF, Benjamin SB. Gastric polyps: relationship of size and histology to cancer risk. Am J Gastroenterol. 1996;91(4):714–7.PubMed Ginsberg GG, Al-Kawas FH, Fleischer DE, Reilly HF, Benjamin SB. Gastric polyps: relationship of size and histology to cancer risk. Am J Gastroenterol. 1996;91(4):714–7.PubMed
15.
Zurück zum Zitat Muehldorfer SM, Stolte M, Martus P, Hahn EG, Ell C, Multicenter Study Group “Gastric Polyps”. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut. 2002;50(4):465–70.PubMedPubMedCentralCrossRef Muehldorfer SM, Stolte M, Martus P, Hahn EG, Ell C, Multicenter Study Group “Gastric Polyps”. Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut. 2002;50(4):465–70.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Han AR, Sung CO, Kim KM, Park CK, Min BH, Lee JH, et al. The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations: a suggestion of indication for endoscopic polypectomy. Gut Liv. 2009;3(4):271–5.CrossRef Han AR, Sung CO, Kim KM, Park CK, Min BH, Lee JH, et al. The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations: a suggestion of indication for endoscopic polypectomy. Gut Liv. 2009;3(4):271–5.CrossRef
17.
Zurück zum Zitat Chandrasekhara V, Ginsberg GG. Endoscopic management of gastrointestinal stromal tumors. Curr Gastroenterol Rep. 2011;13(6):532–9.PubMedCrossRef Chandrasekhara V, Ginsberg GG. Endoscopic management of gastrointestinal stromal tumors. Curr Gastroenterol Rep. 2011;13(6):532–9.PubMedCrossRef
18.
Zurück zum Zitat Kinoshita Y, Tojo M, Yano T, Kitajima N, Itoh T, Nishiyama K, et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc. 1993;39(2):161–3.PubMedCrossRef Kinoshita Y, Tojo M, Yano T, Kitajima N, Itoh T, Nishiyama K, et al. Incidence of fundic gland polyps in patients without familial adenomatous polyposis. Gastrointest Endosc. 1993;39(2):161–3.PubMedCrossRef
19.
Zurück zum Zitat Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994;26(8):659–65.PubMedCrossRef Stolte M, Sticht T, Eidt S, Ebert D, Finkenzeller G. Frequency, location, and age and sex distribution of various types of gastric polyp. Endoscopy. 1994;26(8):659–65.PubMedCrossRef
20.
Zurück zum Zitat Odze RD, Marcial MA, Antonioli D. Gastric fundic gland polyps: a morphological study including mucin histochemistry, stereometry, and MIB-1 immunohistochemistry. Hum Pathol. 1996;27(9):896–903.PubMedCrossRef Odze RD, Marcial MA, Antonioli D. Gastric fundic gland polyps: a morphological study including mucin histochemistry, stereometry, and MIB-1 immunohistochemistry. Hum Pathol. 1996;27(9):896–903.PubMedCrossRef
21.
Zurück zum Zitat Genta RM, Schuler CM, Robiou CI, Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7(8):849–54.PubMedCrossRef Genta RM, Schuler CM, Robiou CI, Lash RH. No association between gastric fundic gland polyps and gastrointestinal neoplasia in a study of over 100,000 patients. Clin Gastroenterol Hepatol. 2009;7(8):849–54.PubMedCrossRef
22.
Zurück zum Zitat Shaib YH, Rugge M, Graham DY, Genta RM. Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2013;11(11):1374–84.CrossRef Shaib YH, Rugge M, Graham DY, Genta RM. Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc. 2013;11(11):1374–84.CrossRef
23.
Zurück zum Zitat • Levy MD, Bhattacharya B. Sporadic fundic gland polyps with low-grade dysplasia: a large case series evaluating pathologic and immunohistochemical findings and clinical behavior. Am J Clin Pathol. 2015;144(4):592–600. Studied over 35,000 patients with FGPs and drew a case series of those with dysplasia, with specific attention to morphological and immunohistochemical characteristics in addition to follow-up endoscopic findingsPubMedCrossRef • Levy MD, Bhattacharya B. Sporadic fundic gland polyps with low-grade dysplasia: a large case series evaluating pathologic and immunohistochemical findings and clinical behavior. Am J Clin Pathol. 2015;144(4):592–600. Studied over 35,000 patients with FGPs and drew a case series of those with dysplasia, with specific attention to morphological and immunohistochemical characteristics in addition to follow-up endoscopic findingsPubMedCrossRef
24.
Zurück zum Zitat • Nam SY, Park BJ, Ryu KH, Nam JH. Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps. Euro J Gastroenterol Hepatol. 2016;28(4):449–54. Large cohort study looking at the association of H.pylori infection and its eradication on the identification and fate of gastric polyps • Nam SY, Park BJ, Ryu KH, Nam JH. Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps. Euro J Gastroenterol Hepatol. 2016;28(4):449–54. Large cohort study looking at the association of H.pylori infection and its eradication on the identification and fate of gastric polyps
25.
26.
Zurück zum Zitat Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol. 1998;22(3):293–8.PubMedCrossRef Wu TT, Kornacki S, Rashid A, Yardley JH, Hamilton SR. Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol. 1998;22(3):293–8.PubMedCrossRef
27.
Zurück zum Zitat Jalving M, Koornstra JJ, Gotz JM, van der Waaij LA, de Jong S, Zwart N, et al. High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature. Euro J Gastroenterol Hepatol. 2003;15(11):1229–33.CrossRef Jalving M, Koornstra JJ, Gotz JM, van der Waaij LA, de Jong S, Zwart N, et al. High-grade dysplasia in sporadic fundic gland polyps: a case report and review of the literature. Euro J Gastroenterol Hepatol. 2003;15(11):1229–33.CrossRef
28.
Zurück zum Zitat Stolte M, Vieth M, Ebert MP. High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not? Euro J Gastroenterol Hepatol. 2003;15(11):1153–6.CrossRef Stolte M, Vieth M, Ebert MP. High-grade dysplasia in sporadic fundic gland polyps: clinically relevant or not? Euro J Gastroenterol Hepatol. 2003;15(11):1153–6.CrossRef
29.
Zurück zum Zitat Zelter A, Fernandez JL, Bilder C, Rodriguez P, Wonaga A, Dorado F, et al. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies. Dig Dis Sci. 2011;56(6):1743–8.PubMedCrossRef Zelter A, Fernandez JL, Bilder C, Rodriguez P, Wonaga A, Dorado F, et al. Fundic gland polyps and association with proton pump inhibitor intake: a prospective study in 1,780 endoscopies. Dig Dis Sci. 2011;56(6):1743–8.PubMedCrossRef
30.
Zurück zum Zitat Zea-Iriarte WL, Sekine I, Itsuno M, Makiyama K, Naito S, Nakayama T, et al. Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci. 1996;41(2):377–86.PubMedCrossRef Zea-Iriarte WL, Sekine I, Itsuno M, Makiyama K, Naito S, Nakayama T, et al. Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci. 1996;41(2):377–86.PubMedCrossRef
31.
Zurück zum Zitat Arnason T, Liang WY, Alfaro E, Kelly P, Chung DC, Odze RD, et al. Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps. Histopathology. 2014;65(3):353–62.PubMedCrossRef Arnason T, Liang WY, Alfaro E, Kelly P, Chung DC, Odze RD, et al. Morphology and natural history of familial adenomatous polyposis-associated dysplastic fundic gland polyps. Histopathology. 2014;65(3):353–62.PubMedCrossRef
32.
Zurück zum Zitat Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;2(8666):783–5.PubMedCrossRef Spigelman AD, Williams CB, Talbot IC, Domizio P, Phillips RK. Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet. 1989;2(8666):783–5.PubMedCrossRef
33.
Zurück zum Zitat Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992;102(6):1980–2.PubMedCrossRef Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology. 1992;102(6):1980–2.PubMedCrossRef
34.
Zurück zum Zitat Odze RD, Quinn PS, Terrault NA, Vivona AA, Ward MA, Cohen Z, et al. Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol. 1993;24(4):442–8.PubMedCrossRef Odze RD, Quinn PS, Terrault NA, Vivona AA, Ward MA, Cohen Z, et al. Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. Hum Pathol. 1993;24(4):442–8.PubMedCrossRef
35.
Zurück zum Zitat Zwick A, Munir M, Ryan CK, Gian J, Burt RW, Leppert M, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology. 1997;113(2):659–63.PubMedCrossRef Zwick A, Munir M, Ryan CK, Gian J, Burt RW, Leppert M, et al. Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology. 1997;113(2):659–63.PubMedCrossRef
36.
Zurück zum Zitat Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg. 1998;85(6):742–50.PubMedCrossRef Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg. 1998;85(6):742–50.PubMedCrossRef
37.
Zurück zum Zitat Hofgartner WT, Thorp M, Ramus MW, Delorefice G, Chey WY, Ryan CK, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol. 1999;94(8):2275–81.PubMedCrossRef Hofgartner WT, Thorp M, Ramus MW, Delorefice G, Chey WY, Ryan CK, et al. Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol. 1999;94(8):2275–81.PubMedCrossRef
38.
Zurück zum Zitat Attard TM, Cuffari C, Tajouri T, Stoner JA, Eisenberg MT, Yardley JH, et al. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol. 2004;99(4):681–6.PubMedCrossRef Attard TM, Cuffari C, Tajouri T, Stoner JA, Eisenberg MT, Yardley JH, et al. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol. 2004;99(4):681–6.PubMedCrossRef
39.
Zurück zum Zitat Sekine S, Shimoda T, Nimura S, Nakanishi Y, Akasu T, Katai H, et al. High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod Pathol. 2004;17(11):1421–6.PubMedCrossRef Sekine S, Shimoda T, Nimura S, Nakanishi Y, Akasu T, Katai H, et al. High-grade dysplasia associated with fundic gland polyposis in a familial adenomatous polyposis patient, with special reference to APC mutation profiles. Mod Pathol. 2004;17(11):1421–6.PubMedCrossRef
40.
Zurück zum Zitat Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6(2):180–5.PubMedCrossRef Bianchi LK, Burke CA, Bennett AE, Lopez R, Hasson H, Church JM. Fundic gland polyp dysplasia is common in familial adenomatous polyposis. Clin Gastroenterol Hepatol. 2008;6(2):180–5.PubMedCrossRef
41.
Zurück zum Zitat Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Path. 2001;158(3):1005–10.PubMedPubMedCentralCrossRef Abraham SC, Nobukawa B, Giardiello FM, Hamilton SR, Wu TT. Sporadic fundic gland polyps: common gastric polyps arising through activating mutations in the beta-catenin gene. Am J Path. 2001;158(3):1005–10.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Sekine S, Shibata T, Yamauchi Y, Nakanishi Y, Shimoda T, Sakamoto M, et al. Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch. 2002;440(4):381–6.PubMedCrossRef Sekine S, Shibata T, Yamauchi Y, Nakanishi Y, Shimoda T, Sakamoto M, et al. Beta-catenin mutations in sporadic fundic gland polyps. Virchows Arch. 2002;440(4):381–6.PubMedCrossRef
43.
Zurück zum Zitat Abraham SC, Park SJ, Mugartegui L, Hamilton SR, Wu TT. Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Path. 2002;161(5):1735–42.PubMedPubMedCentralCrossRef Abraham SC, Park SJ, Mugartegui L, Hamilton SR, Wu TT. Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Path. 2002;161(5):1735–42.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119(4):807–14.PubMedCrossRef Aretz S, Uhlhaas S, Goergens H, Siberg K, Vogel M, Pagenstecher C, et al. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype. Int J Cancer. 2006;119(4):807–14.PubMedCrossRef
45.
Zurück zum Zitat Bouguen G, Manfredi S, Blayau M, Dugast C, Buecher B, Bonneau D, et al. Colorectal adenomatous polyposis associated with MYH mutations: genotype and phenotype characteristics. Dis Colon Rectum. 2007;50(10):1612–7.PubMedCrossRef Bouguen G, Manfredi S, Blayau M, Dugast C, Buecher B, Bonneau D, et al. Colorectal adenomatous polyposis associated with MYH mutations: genotype and phenotype characteristics. Dis Colon Rectum. 2007;50(10):1612–7.PubMedCrossRef
46.
Zurück zum Zitat Abraham SC. Fundic gland polyps: common and occasionally problematic lesions. Gastroenterol Hepatol (N Y). 2010;6(1):48–51. Abraham SC. Fundic gland polyps: common and occasionally problematic lesions. Gastroenterol Hepatol (N Y). 2010;6(1):48–51.
47.
Zurück zum Zitat Worthley DL, Phillips KD, Wayte N, Schrader KA, Healey S, Kaurah P, et al. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 2012;61(5):774–9.PubMedCrossRef Worthley DL, Phillips KD, Wayte N, Schrader KA, Healey S, Kaurah P, et al. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. Gut. 2012;61(5):774–9.PubMedCrossRef
48.
Zurück zum Zitat Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS, et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Human Genet. 2016;98(5):830–42.CrossRef Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS, et al. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. Am J Human Genet. 2016;98(5):830–42.CrossRef
49.
Zurück zum Zitat Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137(6):1976–85.e1-10.PubMedCrossRef Vogt S, Jones N, Christian D, Engel C, Nielsen M, Kaufmann A, et al. Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology. 2009;137(6):1976–85.e1-10.PubMedCrossRef
50.
Zurück zum Zitat Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Austral. 1992;157(4):287–8.PubMed Graham JR. Gastric polyposis: onset during long-term therapy with omeprazole. Med J Austral. 1992;157(4):287–8.PubMed
51.
52.
Zurück zum Zitat el-Zimaity HM, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol. 1997;92(10):1858–60.PubMed el-Zimaity HM, Jackson FW, Graham DY. Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol. 1997;92(10):1858–60.PubMed
53.
Zurück zum Zitat Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998;110(5):615–21.PubMedCrossRef Choudhry U, Boyce HW Jr, Coppola D. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol. 1998;110(5):615–21.PubMedCrossRef
54.
Zurück zum Zitat •• Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(12):1706–19.e5. Major systematic review and meta-analyses on the use of PPIs and their association with an increased likelihood of identification of FGPs on EGDPubMedCrossRef •• Tran-Duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(12):1706–19.e5. Major systematic review and meta-analyses on the use of PPIs and their association with an increased likelihood of identification of FGPs on EGDPubMedCrossRef
55.
Zurück zum Zitat Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122(10):896–903.PubMedCrossRef Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122(10):896–903.PubMedCrossRef
56.
Zurück zum Zitat Palmer RH. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(5):790.PubMedCrossRef Palmer RH. Use of proton pump inhibitors and risks of fundic gland polyps and gastric cancer: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(5):790.PubMedCrossRef
57.
Zurück zum Zitat Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116(5):716–20.PubMedCrossRef Vieth M, Stolte M. Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol. 2001;116(5):716–20.PubMedCrossRef
58.
Zurück zum Zitat Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 1995;27(1):32–7. discussion 59-60 Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 1995;27(1):32–7. discussion 59-60
59.
Zurück zum Zitat Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 1995;27(1):32–7. discussion 59-60 Stolte M. Clinical consequences of the endoscopic diagnosis of gastric polyps. Endoscopy. 1995;27(1):32–7. discussion 59-60
60.
Zurück zum Zitat Morais DJ, Yamanaka A, Zeitune JM, Andreollo NA. Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol. 2007;44(1):14–7.PubMedCrossRef Morais DJ, Yamanaka A, Zeitune JM, Andreollo NA. Gastric polyps: a retrospective analysis of 26,000 digestive endoscopies. Arq Gastroenterol. 2007;44(1):14–7.PubMedCrossRef
61.
Zurück zum Zitat Al-Haddad M, Ward EM, Bouras EP, Raimondo M. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss. Dig Dis Sci. 2007;52(1):105–9.PubMedCrossRef Al-Haddad M, Ward EM, Bouras EP, Raimondo M. Hyperplastic polyps of the gastric antrum in patients with gastrointestinal blood loss. Dig Dis Sci. 2007;52(1):105–9.PubMedCrossRef
62.
Zurück zum Zitat Abraham SC, Singh VK, Yardley JH, Wu TT. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25(4):500–7.PubMedCrossRef Abraham SC, Singh VK, Yardley JH, Wu TT. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25(4):500–7.PubMedCrossRef
63.
Zurück zum Zitat Markowski AR, Markowska A, Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol. 2016;22(40):8883–91.PubMedPubMedCentralCrossRef Markowski AR, Markowska A, Guzinska-Ustymowicz K. Pathophysiological and clinical aspects of gastric hyperplastic polyps. World J Gastroenterol. 2016;22(40):8883–91.PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Ohkusa T, Takashimizu I, Fujiki K, Suzuki S, Shimoi K, Horiuchi T, et al. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med. 1998;129(9):712–5.PubMedCrossRef Ohkusa T, Takashimizu I, Fujiki K, Suzuki S, Shimoi K, Horiuchi T, et al. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med. 1998;129(9):712–5.PubMedCrossRef
65.
Zurück zum Zitat Ljubicic N, Banic M, Kujundzic M, Antic Z, Vrkljan M, Kovacevic I, et al. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Euro J Gastroenterol Hepatol. 1999;11(7):727–30.CrossRef Ljubicic N, Banic M, Kujundzic M, Antic Z, Vrkljan M, Kovacevic I, et al. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Euro J Gastroenterol Hepatol. 1999;11(7):727–30.CrossRef
66.
Zurück zum Zitat Ji F, Wang ZW, Ning JW, Wang QY, Chen JY, Li YM. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World J Wastroenterol. 2006;12(11):1770–3.CrossRef Ji F, Wang ZW, Ning JW, Wang QY, Chen JY, Li YM. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World J Wastroenterol. 2006;12(11):1770–3.CrossRef
67.
Zurück zum Zitat Suzuki S, Ohkusa T, Shimoi K, Horiuchi T, Fujiki K, Takashimizu I. Disappearance of multiple hyperplastic polyps after the eradication of Helicobacter pylori. Gastrointest Endosc. 1997;46(6):566–8.PubMedCrossRef Suzuki S, Ohkusa T, Shimoi K, Horiuchi T, Fujiki K, Takashimizu I. Disappearance of multiple hyperplastic polyps after the eradication of Helicobacter pylori. Gastrointest Endosc. 1997;46(6):566–8.PubMedCrossRef
68.
Zurück zum Zitat Kume K, Hirakoba M, Murata I, Yoshikawa I, Otsuki M. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Am J Gastroenterol. 2001;96(9):2796–7.PubMedCrossRef Kume K, Hirakoba M, Murata I, Yoshikawa I, Otsuki M. Disappearance of both MALT lymphoma and hyperplastic polyps in the stomach after eradication of Helicobacter pylori. Am J Gastroenterol. 2001;96(9):2796–7.PubMedCrossRef
69.
Zurück zum Zitat Ohkusa T, Miwa H, Hojo M, Kumagai J, Tanizawa T, Asaoka D, et al. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Digestion. 2003;68(2–3):57–62.PubMedCrossRef Ohkusa T, Miwa H, Hojo M, Kumagai J, Tanizawa T, Asaoka D, et al. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Digestion. 2003;68(2–3):57–62.PubMedCrossRef
70.
Zurück zum Zitat Horvath B, Pai RK. Prevalence of Helicobacter pylori in gastric hyperplastic polyps. Int J Surg Pathol. 2016;24(8):704–8.PubMedCrossRef Horvath B, Pai RK. Prevalence of Helicobacter pylori in gastric hyperplastic polyps. Int J Surg Pathol. 2016;24(8):704–8.PubMedCrossRef
71.
Zurück zum Zitat Kumar A, Quick CR, Carr-Locke DL. Prolapsing gastric polyp, an unusual cause of gastric outlet obstruction: a review of the pathology and management of gastric polyps. Endoscopy. 1996;28(5):452–5.PubMedCrossRef Kumar A, Quick CR, Carr-Locke DL. Prolapsing gastric polyp, an unusual cause of gastric outlet obstruction: a review of the pathology and management of gastric polyps. Endoscopy. 1996;28(5):452–5.PubMedCrossRef
72.
Zurück zum Zitat Ahn JY, Son DH, Choi KD, Roh J, Lim H, Choi KS, et al. Neoplasms arising in large gastric hyperplastic polyps: endoscopic and pathologic features. Gastrointest Endosc. 2014;80(6):1005–13.e2.PubMedCrossRef Ahn JY, Son DH, Choi KD, Roh J, Lim H, Choi KS, et al. Neoplasms arising in large gastric hyperplastic polyps: endoscopic and pathologic features. Gastrointest Endosc. 2014;80(6):1005–13.e2.PubMedCrossRef
73.
Zurück zum Zitat Omori T, Kamiya Y, Tahara T, Shibata T, Nakamura M, Yonemura J, et al. Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions: a pilot feasibility trial. BMC Gastroenterol. 2012;12:17.PubMedPubMedCentralCrossRef Omori T, Kamiya Y, Tahara T, Shibata T, Nakamura M, Yonemura J, et al. Correlation between magnifying narrow band imaging and histopathology in gastric protruding/or polypoid lesions: a pilot feasibility trial. BMC Gastroenterol. 2012;12:17.PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Varis O, Laxen F, Valle J. Helicobacter pylori infection and fasting serum gastrin levels in a series of endoscopically diagnosed gastric polyps. APMIS. 1994;102(10):759–64.PubMedCrossRef Varis O, Laxen F, Valle J. Helicobacter pylori infection and fasting serum gastrin levels in a series of endoscopically diagnosed gastric polyps. APMIS. 1994;102(10):759–64.PubMedCrossRef
75.
Zurück zum Zitat Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010;71(3):513–8.PubMedCrossRef Park WG, Yan BM, Schellenberg D, Kim J, Chang DT, Koong A, et al. EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer: 50 successful cases without fluoroscopy. Gastrointest Endosc. 2010;71(3):513–8.PubMedCrossRef
76.
Zurück zum Zitat Gonzalez-Obeso E, Fujita H, Deshpande V, Ogawa F, Lisovsky M, Genevay M, et al. Gastric hyperplastic polyps: a heterogeneous clinicopathologic group including a distinct subset best categorized as mucosal prolapse polyp. Am J Surg Pathol. 2011;35(5):670–7.PubMedCrossRef Gonzalez-Obeso E, Fujita H, Deshpande V, Ogawa F, Lisovsky M, Genevay M, et al. Gastric hyperplastic polyps: a heterogeneous clinicopathologic group including a distinct subset best categorized as mucosal prolapse polyp. Am J Surg Pathol. 2011;35(5):670–7.PubMedCrossRef
77.
Zurück zum Zitat Carmack SW, Genta RM, Graham DY, Lauwers GY. Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol. 2009;6(6):331–41.PubMedCrossRef Carmack SW, Genta RM, Graham DY, Lauwers GY. Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol. 2009;6(6):331–41.PubMedCrossRef
78.
Zurück zum Zitat Orlowska J, Pietrow D. Multifocal gastric carcinoma arising from hyperplastic and adenomatous polyps. Am J Gastroenterol. 1990;85(12):1629–34.PubMed Orlowska J, Pietrow D. Multifocal gastric carcinoma arising from hyperplastic and adenomatous polyps. Am J Gastroenterol. 1990;85(12):1629–34.PubMed
79.
Zurück zum Zitat Cristallini EG, Ascani S, Bolis GB. Association between histologic type of polyp and carcinoma in the stomach. Gastrointest Endosc. 1992;38(4):481–4.PubMedCrossRef Cristallini EG, Ascani S, Bolis GB. Association between histologic type of polyp and carcinoma in the stomach. Gastrointest Endosc. 1992;38(4):481–4.PubMedCrossRef
80.
Zurück zum Zitat Rosen S, Hoak D. Intramucosal carcinoma developing in a hyperplastic gastric polyp. Gastrointest Endosc. 1993;39(6):830–3.PubMedCrossRef Rosen S, Hoak D. Intramucosal carcinoma developing in a hyperplastic gastric polyp. Gastrointest Endosc. 1993;39(6):830–3.PubMedCrossRef
81.
Zurück zum Zitat Hizawa K, Fuchigami T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, et al. Possible neoplastic transformation within gastric hyperplastic polyp. Application of endoscopic polypectomy. Surg Endosc. 1995;9(6):714–8.PubMedCrossRef Hizawa K, Fuchigami T, Iida M, Aoyagi K, Iwashita A, Daimaru Y, et al. Possible neoplastic transformation within gastric hyperplastic polyp. Application of endoscopic polypectomy. Surg Endosc. 1995;9(6):714–8.PubMedCrossRef
82.
Zurück zum Zitat Orlowska J, Jarosz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am JGastroenterol. 1995;90(12):2152–9. Orlowska J, Jarosz D, Pachlewski J, Butruk E. Malignant transformation of benign epithelial gastric polyps. Am JGastroenterol. 1995;90(12):2152–9.
83.
Zurück zum Zitat Murakami K, Mitomi H, Yamashita K, Tanabe S, Saigenji K, Okayasu I. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol. 2001;115(2):224–34.PubMedCrossRef Murakami K, Mitomi H, Yamashita K, Tanabe S, Saigenji K, Okayasu I. p53, but not c-Ki-ras, mutation and down-regulation of p21WAF1/CIP1 and cyclin D1 are associated with malignant transformation in gastric hyperplastic polyps. Am J Clin Pathol. 2001;115(2):224–34.PubMedCrossRef
84.
Zurück zum Zitat Dirschmid K, Platz-Baudin C, Stolte M. Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch. 2006;448(1):80–4.PubMedCrossRef Dirschmid K, Platz-Baudin C, Stolte M. Why is the hyperplastic polyp a marker for the precancerous condition of the gastric mucosa? Virchows Arch. 2006;448(1):80–4.PubMedCrossRef
85.
Zurück zum Zitat Park DY, Lauwers GY. Gastric polyps: classification and management. Arch Pathol Lab Med. 2008;132(4):633–40.PubMed Park DY, Lauwers GY. Gastric polyps: classification and management. Arch Pathol Lab Med. 2008;132(4):633–40.PubMed
86.
87.
Zurück zum Zitat Dang S, McElreath DP, Kumar S, Kakati B, Atiq M, Morton WJ, et al. Giant gastric hyperplastic polyp: not always a benign lesion. J Ark Med Soc. 2010;107(5):89–92.PubMed Dang S, McElreath DP, Kumar S, Kakati B, Atiq M, Morton WJ, et al. Giant gastric hyperplastic polyp: not always a benign lesion. J Ark Med Soc. 2010;107(5):89–92.PubMed
88.
Zurück zum Zitat Kang HM, Oh TH, Seo JY, Joen TJ, Seo DD, Shin WC, et al. Clinical factors predicting for neoplastic transformation of gastric hyperplastic polyps. Kor J Gastroenterol. 2011;58(4):184–9.CrossRef Kang HM, Oh TH, Seo JY, Joen TJ, Seo DD, Shin WC, et al. Clinical factors predicting for neoplastic transformation of gastric hyperplastic polyps. Kor J Gastroenterol. 2011;58(4):184–9.CrossRef
89.
Zurück zum Zitat Terada T. Malignant transformation of foveolar hyperplastic polyp of the stomach: a histopathological study. Med Oncol. 2011;28(4):941–4.PubMedCrossRef Terada T. Malignant transformation of foveolar hyperplastic polyp of the stomach: a histopathological study. Med Oncol. 2011;28(4):941–4.PubMedCrossRef
90.
Zurück zum Zitat Imura J, Hayashi S, Ichikawa K, Miwa S, Nakajima T, Nomoto K, et al. Malignant transformation of hyperplastic gastric polyps: an immunohistochemical and pathological study of the changes of neoplastic phenotype. Oncol Lett. 2014;7(5):1459–63.PubMedPubMedCentral Imura J, Hayashi S, Ichikawa K, Miwa S, Nakajima T, Nomoto K, et al. Malignant transformation of hyperplastic gastric polyps: an immunohistochemical and pathological study of the changes of neoplastic phenotype. Oncol Lett. 2014;7(5):1459–63.PubMedPubMedCentral
91.
Zurück zum Zitat Committee ASoP, Evans JA, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc. 2015;82(1):1–8.CrossRef Committee ASoP, Evans JA, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, et al. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc. 2015;82(1):1–8.CrossRef
92.
Zurück zum Zitat Markowski AR, Guzinska-Ustymowicz K. Gastric hyperplastic polyp with focal cancer. Gastroenterol Rep (Oxf). 2016;4(2):158–61.CrossRef Markowski AR, Guzinska-Ustymowicz K. Gastric hyperplastic polyp with focal cancer. Gastroenterol Rep (Oxf). 2016;4(2):158–61.CrossRef
93.
Zurück zum Zitat Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.PubMedCrossRef Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.PubMedCrossRef
94.
Zurück zum Zitat Committee ASoP, Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78(2):216–24.CrossRef Committee ASoP, Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78(2):216–24.CrossRef
95.
Zurück zum Zitat Cao H, He N, Song S, Xu M, Piao M, Yan F, et al. Is surveillance colonoscopy necessary for patients with sporadic gastric hyperplastic polyps? PLoS One. 2015;10(4):e0122996.PubMedPubMedCentralCrossRef Cao H, He N, Song S, Xu M, Piao M, Yan F, et al. Is surveillance colonoscopy necessary for patients with sporadic gastric hyperplastic polyps? PLoS One. 2015;10(4):e0122996.PubMedPubMedCentralCrossRef
96.
Zurück zum Zitat Lewin KJ. Nomenclature problems of gastrointestinal epithelial neoplasia. Am J Surg Pathol. 1998;22(9):1043–7.PubMedCrossRef Lewin KJ. Nomenclature problems of gastrointestinal epithelial neoplasia. Am J Surg Pathol. 1998;22(9):1043–7.PubMedCrossRef
97.
Zurück zum Zitat Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol. 1997;28(2):127–33.PubMedCrossRef Goldstein NS, Lewin KJ. Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading. Hum Pathol. 1997;28(2):127–33.PubMedCrossRef
98.
Zurück zum Zitat Schmitz JM, Stolte M. Gastric polyps as precancerous lesions. Gastrointest Endosc Clin N Am. 1997;7(1):29–46.PubMed Schmitz JM, Stolte M. Gastric polyps as precancerous lesions. Gastrointest Endosc Clin N Am. 1997;7(1):29–46.PubMed
99.
Zurück zum Zitat Saito K, Arai K, Mori M, Kobayashi R, Ohki I. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. Gastrointest Endosc. 2000;52(1):27–32.PubMedCrossRef Saito K, Arai K, Mori M, Kobayashi R, Ohki I. Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma. Gastrointest Endosc. 2000;52(1):27–32.PubMedCrossRef
100.
Zurück zum Zitat Tomasulo J. Gastric polyps. Histologic types and their relationship to gastric carcinoma. Cancer. 1971;27(6):1346–55.PubMedCrossRef Tomasulo J. Gastric polyps. Histologic types and their relationship to gastric carcinoma. Cancer. 1971;27(6):1346–55.PubMedCrossRef
101.
Zurück zum Zitat Kamiya T, Morishita T, Asakura H, Miura S, Munakata Y, Tsuchiya M. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer. 1982;50(11):2496–503.PubMedCrossRef Kamiya T, Morishita T, Asakura H, Miura S, Munakata Y, Tsuchiya M. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer. 1982;50(11):2496–503.PubMedCrossRef
102.
Zurück zum Zitat Antonioli DA. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol. 1994;25(10):994–1005.PubMedCrossRef Antonioli DA. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol. 1994;25(10):994–1005.PubMedCrossRef
103.
Zurück zum Zitat Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T, et al. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Cancer. 1994;74(11):2896–907.PubMedCrossRef Kolodziejczyk P, Yao T, Oya M, Nakamura S, Utsunomiya T, Ishikawa T, et al. Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis. Cancer. 1994;74(11):2896–907.PubMedCrossRef
104.
Zurück zum Zitat Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40(8):650–8.PubMedCrossRef Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al. OLGA staging for gastritis: a tutorial. Dig Liver Dis. 2008;40(8):650–8.PubMedCrossRef
105.
Zurück zum Zitat Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol. 2000;24(2):167–76.PubMedCrossRef Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol. 2000;24(2):167–76.PubMedCrossRef
106.
Zurück zum Zitat Rugge M, Nitti D, Farinati F, di Mario F, Genta RM. Non-invasive neoplasia of the stomach. Euro J Gastroenterol Hepatol. 2005;17(11):1191–6.CrossRef Rugge M, Nitti D, Farinati F, di Mario F, Genta RM. Non-invasive neoplasia of the stomach. Euro J Gastroenterol Hepatol. 2005;17(11):1191–6.CrossRef
107.
Zurück zum Zitat Kim YJ, Park JC, Kim JH, Shin SK, Lee SK, Lee YC, et al. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy. 2010;42(8):620–6.PubMedCrossRef Kim YJ, Park JC, Kim JH, Shin SK, Lee SK, Lee YC, et al. Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesions. Endoscopy. 2010;42(8):620–6.PubMedCrossRef
108.
Zurück zum Zitat Choi CW, Kang DH, Kim HW, Park SB, Kim S, Cho M. Endoscopic submucosal dissection as a treatment for gastric adenomatous polyps: predictive factors for early gastric cancer. Scand J Gastroenterol. 2012;47(10):1218–25.PubMedCrossRef Choi CW, Kang DH, Kim HW, Park SB, Kim S, Cho M. Endoscopic submucosal dissection as a treatment for gastric adenomatous polyps: predictive factors for early gastric cancer. Scand J Gastroenterol. 2012;47(10):1218–25.PubMedCrossRef
109.
Zurück zum Zitat Sakurai U, Lauwers GY, Vieth M, Sawabe M, Arai T, Yoshida T, et al. Gastric high-grade dysplasia can be associated with submucosal invasion: evaluation of its prevalence in a series of 121 endoscopically resected specimens. Am J Surg Pathol. 2014;38(11):1545–50.PubMedCrossRef Sakurai U, Lauwers GY, Vieth M, Sawabe M, Arai T, Yoshida T, et al. Gastric high-grade dysplasia can be associated with submucosal invasion: evaluation of its prevalence in a series of 121 endoscopically resected specimens. Am J Surg Pathol. 2014;38(11):1545–50.PubMedCrossRef
110.
Zurück zum Zitat Facciorusso A, Antonino M, Di Maso M, Muscatiello N. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc. 2014;6(11):555–63.PubMedPubMedCentralCrossRef Facciorusso A, Antonino M, Di Maso M, Muscatiello N. Endoscopic submucosal dissection vs endoscopic mucosal resection for early gastric cancer: a meta-analysis. World J Gastrointest Endosc. 2014;6(11):555–63.PubMedPubMedCentralCrossRef
111.
Zurück zum Zitat Yoon SB, Park JM, Lim CH, Kim JS, Cho YK, Lee BI, et al. Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc. 2016;83(6):1176–83.PubMedCrossRef Yoon SB, Park JM, Lim CH, Kim JS, Cho YK, Lee BI, et al. Incidence of gastric cancer after endoscopic resection of gastric adenoma. Gastrointest Endosc. 2016;83(6):1176–83.PubMedCrossRef
112.
Zurück zum Zitat Kim SY, Sung JK, Moon HS, Kim KS, Jung IS, Yoon BY, et al. Is endoscopic mucosal resection a sufficient treatment for low-grade gastric epithelial dysplasia? Gut Liver. 2012;6(4):446–51.PubMedPubMedCentralCrossRef Kim SY, Sung JK, Moon HS, Kim KS, Jung IS, Yoon BY, et al. Is endoscopic mucosal resection a sufficient treatment for low-grade gastric epithelial dysplasia? Gut Liver. 2012;6(4):446–51.PubMedPubMedCentralCrossRef
113.
Zurück zum Zitat Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48(2):436–50.PubMedPubMedCentralCrossRef Oh CM, Won YJ, Jung KW, Kong HJ, Cho H, Lee JK, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat. 2016;48(2):436–50.PubMedPubMedCentralCrossRef
Metadaten
Titel
Current Management of Benign Epithelial Gastric Polyps
verfasst von
Antonio R. Cheesman, MD
David A. Greenwald, MD
Shailja C. Shah, MD
Publikationsdatum
03.10.2017
Verlag
Springer US
Erschienen in
Current Treatment Options in Gastroenterology / Ausgabe 4/2017
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI
https://doi.org/10.1007/s11938-017-0159-6

Weitere Artikel der Ausgabe 4/2017

Current Treatment Options in Gastroenterology 4/2017 Zur Ausgabe

Pancreas (V Chandrasekhara, Section Editor)

Diagnosis and Management of Autoimmune Pancreatitis

Motility (H Parkman and R Schey, Section Editors)

Diabetes and the Small Intestine

Motility (H Parkman and R Schey, Section Editors)

Diabetes and the Pancreatobiliary Diseases

Motility (H Parkman and R Schey, Section Editors)

Diabetes Mellitus and the Colon

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.